These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

585 related items for PubMed ID: 17460459

  • 1. Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma.
    Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J.
    Am J Surg Pathol; 2007 May; 31(5):744-51. PubMed ID: 17460459
    [Abstract] [Full Text] [Related]

  • 2. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
    de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter GG, Meijers-Heijboer H, Brocker-Vriends A, Stormorken A, Moller P, Menko F, Cornelisse CJ, Morreau H.
    J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
    [Abstract] [Full Text] [Related]

  • 3. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K, Leitao MM, Kauff ND, Hansen J, Kosarin K, Shia J, Soslow RA.
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [Abstract] [Full Text] [Related]

  • 4. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC, Mariappan MR, Putcha GV, Husain A, Chun N, Ford JM, Schrijver I, Longacre TA.
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [Abstract] [Full Text] [Related]

  • 5. Microsatellite instability and DNA mismatch repair deficiency testing in hereditary and sporadic gastrointestinal cancers.
    Gologan A, Sepulveda AR.
    Clin Lab Med; 2005 Mar; 25(1):179-96. PubMed ID: 15749237
    [Abstract] [Full Text] [Related]

  • 6. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer.
    Shia J, Black D, Hummer AJ, Boyd J, Soslow RA.
    Hum Pathol; 2008 Jan; 39(1):116-25. PubMed ID: 17949789
    [Abstract] [Full Text] [Related]

  • 7. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
    Shia J, Klimstra DS, Nafa K, Offit K, Guillem JG, Markowitz AJ, Gerald WL, Ellis NA.
    Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
    [Abstract] [Full Text] [Related]

  • 8. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium.
    Shannon C, Kirk J, Barnetson R, Evans J, Schnitzler M, Quinn M, Hacker N, Crandon A, Harnett P.
    Clin Cancer Res; 2003 Apr; 9(4):1387-92. PubMed ID: 12684409
    [Abstract] [Full Text] [Related]

  • 9. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma.
    Bao F, Panarelli NC, Rennert H, Sherr DL, Yantiss RK.
    Am J Surg Pathol; 2010 Dec; 34(12):1798-804. PubMed ID: 21107085
    [Abstract] [Full Text] [Related]

  • 10. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes.
    Mead LJ, Jenkins MA, Young J, Royce SG, Smith L, St John DJ, Macrae F, Giles GG, Hopper JL, Southey MC.
    Clin Cancer Res; 2007 May 15; 13(10):2865-9. PubMed ID: 17504984
    [Abstract] [Full Text] [Related]

  • 11. High frequency of microsatellite instability and loss of mismatch-repair protein expression in patients with double primary tumors of the endometrium and colorectum.
    Planck M, Rambech E, Möslein G, Müller W, Olsson H, Nilbert M.
    Cancer; 2002 May 01; 94(9):2502-10. PubMed ID: 12015776
    [Abstract] [Full Text] [Related]

  • 12. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C, Dallenbach-Hellweg G, Schmidt D, Baehring J, Bielau S, von Knebel Doeberitz M, Gebert J.
    Int J Gynecol Pathol; 2004 Jan 01; 23(1):18-25. PubMed ID: 14668545
    [Abstract] [Full Text] [Related]

  • 13. Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers.
    Wong YF, Cheung TH, Lo KW, Yim SF, Chan LK, Buhard O, Duval A, Chung TK, Hamelin R.
    Carcinogenesis; 2006 May 01; 27(5):951-5. PubMed ID: 16490738
    [Abstract] [Full Text] [Related]

  • 14. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST, Lee J, Park SH, Park JO, Lim HY, Kang WK, Kim JY, Kim YH, Chang DK, Rhee PL, Kim DS, Yun H, Cho YB, Kim HC, Yun SH, Lee WY, Chun HK, Park YS.
    Cancer Chemother Pharmacol; 2010 Sep 01; 66(4):659-67. PubMed ID: 20033812
    [Abstract] [Full Text] [Related]

  • 15. Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.
    Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF.
    J Clin Oncol; 2007 Sep 20; 25(27):4231-8. PubMed ID: 17878476
    [Abstract] [Full Text] [Related]

  • 16. Heterogenous MSH6 loss is a result of microsatellite instability within MSH6 and occurs in sporadic and hereditary colorectal and endometrial carcinomas.
    Graham RP, Kerr SE, Butz ML, Thibodeau SN, Halling KC, Smyrk TC, Dina MA, Waugh VM, Rumilla KM.
    Am J Surg Pathol; 2015 Oct 20; 39(10):1370-6. PubMed ID: 26099011
    [Abstract] [Full Text] [Related]

  • 17. Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters.
    Hashmi AA, Mudassir G, Hashmi RN, Irfan M, Asif H, Khan EY, Abu Bakar SM, Faridi N.
    Asian Pac J Cancer Prev; 2019 Sep 01; 20(9):2601-2606. PubMed ID: 31554352
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G, Clarkson A, Shi A, Langford E, Leung H, Eckstein RP, Gill AJ.
    Pathology; 2010 Sep 01; 42(5):409-13. PubMed ID: 20632815
    [Abstract] [Full Text] [Related]

  • 19. Towards identification of hereditary DNA mismatch repair deficiency: sebaceous neoplasm warrants routine immunohistochemical screening regardless of patient's age or other clinical characteristics.
    Orta L, Klimstra DS, Qin J, Mecca P, Tang LH, Busam KJ, Shia J.
    Am J Surg Pathol; 2009 Jun 01; 33(6):934-44. PubMed ID: 19342947
    [Abstract] [Full Text] [Related]

  • 20. Correlation of microsatellite status, proliferation, apoptotic and selected immunohistochemical markers in colorectal carcinoma studied with tissue microarray.
    Okoń K, Demczuk S, Klimkowska A, Wójcik P, Osuch C, Papla B, Stachura J.
    Pol J Pathol; 2006 Jun 01; 57(2):105-11. PubMed ID: 17019973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.